Natural suppression of human immunodeficiency virus type 1 replication is mediated by transitional memory CD8+ T cells

Journal of Virology

Volumn 85, Issue 4, 2011, Pages 1696-1705

  Killian, M Scott ^a   Johnson, Carl ^a   Teque, Fernando ^a   Fujimura, Sue ^a   Levy, Jay A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD27 ANTIGEN; CD45RA ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIVIRAL ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MEMORY CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; VIREMIA; VIRUS REPLICATION;

ADULT; ANTIGENS, CD; APOPTOSIS REGULATORY PROTEINS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS; VIRAL LOAD; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 78951469987     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01120-10     Document Type: Article

References (54)

1. Appay, V., et al. 2000. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192:63-75.
2. Barker, E., K. N. Bossart, S. H. Fujimura, and J. A. Levy. 1997. CD28 costimulation increases CD8+ cell suppression of HIV replication. J. Immunol. 159:5123-5131.
3. Barker, E., et al. 1998. Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome. Blood 92:3105-3114.
4. Betts, M. R., et al. 2003. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281:65-78.
5. Blackbourn, D. J., et al. 1997. CD8+ cells from HIV-2-infected baboons control HIV replication. AIDS 11:737-746.
6. Blackbourn, D. J., et al. 1996. Suppression of HIV replication by lymphoid tissue CD8+ cells correlates with the clinical state of HIV-infected individuals. Proc. Natl. Acad. Sci. U. S. A. 93:13125-13130.
7. Castelli, J. C., S. G. Deeks, S. Shiboski, and J. A. Levy. 2002. Relationship of CD8(+) T cell noncytotoxic anti-HIV response to CD4(+) T cell number in untreated asymptomatic HIV-infected individuals. Blood 99:4225-4227.
8. Champagne, P., et al. 2001. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410:106-111.
9. Chen, C. H., K. J. Weinhold, J. A. Bartlett, D. P. Bolognesi, and M. L. Greenberg. 1993. CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism. AIDS Res. Hum. Retroviruses 9:1079-1086.
10. Christensen, J. E., S. O. Andreasen, J. P. Christensen, and A. R. Thomsen. 2001. CD11b expression as a marker to distinguish between recently activated effector CD8(+) T cells and memory cells. Int. Immunol. 13:593-600.
11. Diaz, L. S., et al. 2005. VCAM-1 expression on CD8+ cells correlates with enhanced anti-HIV suppressing activity. J. Immunol. 174:1574-1579.
12. Freel, S. A., et al. 2010. Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination. J. Virol. 84:4998-5006.
13. Gebhard, D. H., et al. 1999. Progressive expansion of an L-selectin-negative CD8 cell with anti-feline immunodeficiency virus (FIV) suppressor function in the circulation of FIV-infected cats. J. Infect. Dis. 180:1503-1513.
14. Gomez, A. M., F. M. Smaill, and K. L. Rosenthal. 1994. Inhibition of HIV replication by CD8+ T cells correlates with CD4 counts and clinical stage of disease. Clin. Exp. Immunol. 97:68-75.
15. Hamann, D., et al. 1997. Phenotypic and functional separation of memory and effector human CD8+ T cells. J. Exp. Med. 186:1407-1418.
16. Hatano, H., et al. 2009. Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy. J. Virol. 83:329-335.
17. Hoffman, A. D., B. Banapour, and J. A. Levy. 1985. Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology 147:326-335.
18. Hsueh, F. W., C. M. Walker, D. J. Blackbourn, and J. A. Levy. 1994. Suppression of HIV replication by CD8+ cell clones derived from HIV-infected and uninfected individuals. Cell. Immunol. 159:271-279.
19. Killian, M. S., J. Matud, R. Detels, J. V. Giorgi, and B. D. Jamieson. 2002. MaGiK method of T-cell receptor repertoire analysis. Clin. Diagn. Lab. Immunol. 9:858-863.
20. Killian, M. S., et al. 2004. Persistent alterations in the T-cell repertoires of HIV-1-infected and at-risk uninfected men. AIDS 18:161-170.
21. Killian, M. S., S. Ng, C. E. Mackewicz, and J. A. Levy. 2005. A screening assay for detecting CD8(+) cell non-cytotoxic anti-HIV responses. J. Immunol. Methods 304:137-150.
22. Killian, M. S., J. Roop, S. Ng, F. M. Hecht, and J. A. Levy. 2009. CD8+ cell anti-HIV activity rapidly increases upon discontinuation of early antiretroviral therapy. J. Clin. Immunol. 29:311-318.
23. Killian, M. S., et al. 2005. Clonal breadth of the HIV-1-specific T-cell receptor repertoire in vivo as determined by subtractive analysis. AIDS 19:887-896.
24. Kinter, A. L., S. M. Bende, E. C. Hardy, R. Jackson, and A. S. Fauci. 1995. Interleukin 2 induces CD8+ T cell-mediated suppression of human immunodeficiency virus replication in CD4+ T cells and this effect overrides its ability to stimulate virus expression. Proc. Natl. Acad. Sci. U. S. A. 92:10985-10989.
25. Landay, A. L., C. E. Mackewicz, and J. A. Levy. 1993. An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clin. Immunol. Immunopathol. 69:106-116.
26. Levy, J. A. 2003. The search for the CD8+ cell anti-HIV factor (CAF). Trends Immunol. 24:628-632.
27. Levy, J. A., F. Hsueh, D. J. Blackbourn, D. Wara, and P. S. Weintrub. 1998. CD8 cell noncytotoxic antiviral activity in human immunodeficiency virusinfected and -uninfected children. J. Infect. Dis. 177:470-472.
28. Levy, J. A., C. E. Mackewicz, and E. Barker. 1996. Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol. Today 17:217-224.
29. Lieberman, J., P. Shankar, N. Manjunath, and J. Andersson. 2001. Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood 98:1667-1677.
30. MacDonald, H. R., M. Schreyer, R. C. Howe, and C. Bron. 1990. Selective expression of CD8 alpha (Ly-2) subunit on activated thymic gamma/delta cells. Eur. J. Immunol. 20:927-930.
31. Mackewicz, C. E., E. Barker, G. Greco, G. Reyes-Teran, and J. A. Levy. 1997. Do beta-chemokines have clinical relevance in HIV infection? J. Clin. Invest. 100:921-930.
32. Mackewicz, C. E., D. J. Blackbourn, and J. A. Levy. 1995. CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc. Natl. Acad. Sci. U. S. A. 92:2308-2312.
33. Mackewicz, C. E., C. S. Craik, and J. A. Levy. 2003. The CD8+ cell noncytotoxic anti-HIV response can be blocked by protease inhibitors. Proc. Natl. Acad. Sci. U. S. A. 100:3433-3438.
34. Mackewicz, C. E., M. R. Garovoy, and J. A. Levy. 1998. HLA compatibility requirements for CD8(+)-T-cell-mediated suppression of human immunodeficiency virus replication. J. Virol. 72:10165-10170.
35. Mackewicz, C. E., H. W. Ortega, and J. A. Levy. 1991. CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. J. Clin. Invest. 87:1462-1466.
36. Mackewicz, C. E., S. Ridha, and J. A. Levy. 2000. Fas and Fas ligand are not involved in the suppression of HIV replication by CD8 cells. AIDS 14:204-205.
37. Mackewicz, C. E., et al. 2003. Lack of the CD8+ cell anti-HIV factor in CD8+ cell granules. Blood 102:180-183.
38. Mackewicz, C. E., L. C. Yang, J. D. Lifson, and J. A. Levy. 1994. Noncytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection. Lancet 344:1671-1673.
39. Moebius, U., G. Kober, A. L. Griscelli, T. Hercend, and S. C. Meuer. 1991. Expression of different CD8 isoforms on distinct human lymphocyte subpopulations. Eur. J. Immunol. 21:1793-1800.
40. Okazaki, T., and T. Honjo. 2006. The PD-1-PD-L pathway in immunological tolerance. Trends Immunol. 27:195-201.
41. Petrovas, C., et al. 2006. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J. Exp. Med. 203:2281-2292.
42. Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708-712.
43. Schmitz, J. E., et al. 1998. Expression of the CD8alpha beta-heterodimer on CD8(+) T lymphocytes in peripheral blood lymphocytes of human immunodeficiency virus- and human immunodeficiency virus+ individuals. Blood 92:198-206.
44. Stranford, S. A., et al. 2001. Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection. Proc. Natl. Acad. Sci. U. S. A. 98:597-602.
45. Stranford, S. A., et al. 1999. Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response. Proc. Natl. Acad. Sci. U. S. A. 96:1030-1035.
46. Tomiyama, H., T. Matsuda, and M. Takiguchi. 2002. Differentiation of human CD8(+) T cells from a memory to memory/effector phenotype. J. Immunol. 168:5538-5550.
47. Toso, J. F., et al. 1995. Oligoclonal CD8 lymphocytes from persons with asymptomatic human immunodeficiency virus (HIV) type 1 infection inhibit HIV-1 replication. J. Infect. Dis. 172:964-973.
48. Trautmann, L., et al. 2006. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat. Med. 12:1198-1202.
49. van Baarle, D., S. Kostense, M. H. van Oers, D. Hamann, and F. Miedema. 2002. Failing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue. Trends Immunol. 23:586-591.
50. Walker, C. M., A. L. Erickson, F. C. Hsueh, and J. A. Levy. 1991. Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytotoxic mechanism. J. Virol. 65:5921-5927.
51. Walker, C. M., D. J. Moody, D. P. Stites, and J. A. Levy. 1986. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234:1563-1566.
52. Walker, C. M., D. J. Moody, D. P. Stites, and J. A. Levy. 1989. CD8+ T lymphocyte control of HIV replication in cultured CD4+ cells varies among infected individuals. Cell. Immunol. 119:470-475.
53. Walker, C. M., et al. 1991. CD8+ T cells from HIV-1-infected individuals inhibit acute infection by human and primate immunodeficiency viruses. Cell. Immunol. 137:420-428.
54. Wiviott, L. D., C. M. Walker, and J. A. Levy. 1990. CD8+ lymphocytes suppress HIV production by autologous CD4+ cells without eliminating the infected cells from culture. Cell. Immunol. 128:628-634.